Annual EBITDA
-$77.34 M
-$16.95 M-28.06%
31 December 2023
Summary:
HOOKIPA Pharma annual earnings before interest, taxes, depreciation & amortization is currently -$77.34 million, with the most recent change of -$16.95 million (-28.06%) on 31 December 2023. During the last 3 years, it has fallen by -$38.20 million (-97.58%). HOOK annual EBITDA is now -560.20% below its all-time high of -$11.71 million, reached on 31 December 2017.HOOK EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$13.14 M
+$5.24 M+28.51%
30 September 2024
Summary:
HOOKIPA Pharma quarterly earnings before interest, taxes, depreciation & amortization is currently -$13.14 million, with the most recent change of +$5.24 million (+28.51%) on 30 September 2024. Over the past year, it has increased by +$5.39 million (+29.08%). HOOK quarterly EBITDA is now -187.46% below its all-time high of $15.03 million, reached on 31 March 2024.HOOK Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$39.82 M
+$5.39 M+11.92%
30 September 2024
Summary:
HOOKIPA Pharma TTM earnings before interest, taxes, depreciation & amortization is currently -$39.82 million, with the most recent change of +$5.39 million (+11.92%) on 30 September 2024. Over the past year, it has increased by +$25.26 million (+38.81%). HOOK TTM EBITDA is now -844.59% below its all-time high of -$4.22 million, reached on 31 March 2018.HOOK TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HOOK EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -28.1% | +29.1% | +38.8% |
| 3 y3 years | -97.6% | +29.8% | +35.3% |
| 5 y5 years | -422.8% | -21.9% | -22.5% |
HOOK EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -97.6% | at low | -187.5% | +43.7% | at high | +48.5% |
| 5 y | 5 years | -422.8% | at low | -187.5% | +43.7% | -22.5% | +48.5% |
| alltime | all time | -560.2% | at low | -187.5% | +43.7% | -844.6% | +48.5% |
HOOKIPA Pharma EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$13.14 M(-28.5%) | -$39.82 M(-11.9%) |
| June 2024 | - | -$18.38 M(-222.3%) | -$45.21 M(+3.0%) |
| Mar 2024 | - | $15.03 M(-164.4%) | -$43.88 M(-43.3%) |
| Dec 2023 | -$77.34 M(+28.1%) | -$23.33 M(+25.9%) | -$77.34 M(+18.8%) |
| Sept 2023 | - | -$18.53 M(+8.7%) | -$65.08 M(+1.7%) |
| June 2023 | - | -$17.05 M(-7.5%) | -$63.97 M(+2.9%) |
| Mar 2023 | - | -$18.43 M(+66.5%) | -$62.18 M(+3.0%) |
| Dec 2022 | -$60.40 M(-13.9%) | -$11.07 M(-36.4%) | -$60.40 M(-12.6%) |
| Sept 2022 | - | -$17.41 M(+14.1%) | -$69.11 M(-1.8%) |
| June 2022 | - | -$15.26 M(-8.3%) | -$70.41 M(-0.6%) |
| Mar 2022 | - | -$16.65 M(-15.8%) | -$70.86 M(+1.0%) |
| Dec 2021 | -$70.13 M | -$19.78 M(+5.7%) | -$70.13 M(+14.0%) |
| Sept 2021 | - | -$18.71 M(+19.1%) | -$61.51 M(+11.8%) |
| June 2021 | - | -$15.72 M(-1.3%) | -$55.03 M(+21.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$15.92 M(+42.6%) | -$45.27 M(+15.6%) |
| Dec 2020 | -$39.15 M(+0.1%) | -$11.16 M(-8.7%) | -$39.15 M(+8.5%) |
| Sept 2020 | - | -$12.23 M(+105.4%) | -$36.08 M(+4.2%) |
| June 2020 | - | -$5.96 M(-39.2%) | -$34.63 M(-13.6%) |
| Mar 2020 | - | -$9.80 M(+21.0%) | -$40.07 M(+2.5%) |
| Dec 2019 | -$39.09 M(+164.2%) | -$8.10 M(-24.9%) | -$39.09 M(+20.2%) |
| Sept 2019 | - | -$10.78 M(-5.4%) | -$32.51 M(+28.4%) |
| June 2019 | - | -$11.40 M(+29.2%) | -$25.32 M(+30.5%) |
| Mar 2019 | - | -$8.82 M(+481.3%) | -$19.40 M(+31.1%) |
| Dec 2018 | -$14.79 M(+26.3%) | -$1.52 M(-57.7%) | -$14.79 M(+11.4%) |
| Sept 2018 | - | -$3.59 M(-34.5%) | -$13.28 M(+37.0%) |
| June 2018 | - | -$5.48 M(+29.9%) | -$9.69 M(+129.9%) |
| Mar 2018 | - | -$4.22 M | -$4.22 M |
| Dec 2017 | -$11.71 M | - | - |
FAQ
- What is HOOKIPA Pharma annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for HOOKIPA Pharma?
- What is HOOKIPA Pharma annual EBITDA year-on-year change?
- What is HOOKIPA Pharma quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for HOOKIPA Pharma?
- What is HOOKIPA Pharma quarterly EBITDA year-on-year change?
- What is HOOKIPA Pharma TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for HOOKIPA Pharma?
- What is HOOKIPA Pharma TTM EBITDA year-on-year change?
What is HOOKIPA Pharma annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of HOOK is -$77.34 M
What is the all time high annual EBITDA for HOOKIPA Pharma?
HOOKIPA Pharma all-time high annual earnings before interest, taxes, depreciation & amortization is -$11.71 M
What is HOOKIPA Pharma annual EBITDA year-on-year change?
Over the past year, HOOK annual earnings before interest, taxes, depreciation & amortization has changed by -$16.95 M (-28.06%)
What is HOOKIPA Pharma quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of HOOK is -$13.14 M
What is the all time high quarterly EBITDA for HOOKIPA Pharma?
HOOKIPA Pharma all-time high quarterly earnings before interest, taxes, depreciation & amortization is $15.03 M
What is HOOKIPA Pharma quarterly EBITDA year-on-year change?
Over the past year, HOOK quarterly earnings before interest, taxes, depreciation & amortization has changed by +$5.39 M (+29.08%)
What is HOOKIPA Pharma TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of HOOK is -$39.82 M
What is the all time high TTM EBITDA for HOOKIPA Pharma?
HOOKIPA Pharma all-time high TTM earnings before interest, taxes, depreciation & amortization is -$4.22 M
What is HOOKIPA Pharma TTM EBITDA year-on-year change?
Over the past year, HOOK TTM earnings before interest, taxes, depreciation & amortization has changed by +$25.26 M (+38.81%)